Gutiérrez-Aroca Juan Bautista, Ruiz Pilar, Casal Manuel
Manuel Casal, Servicio de Microbiología. Hospital Universitario Reina Sofía, Córdoba, Spain.
Rev Esp Quimioter. 2013 Dec;26(4):332-6.
Although drug resistance in tuberculosis is by no means a new problem, multiple drug resistance is a cause of increasing concern. This study investigated first-line drug resistance in Mycobacterium tuberculosis strains isolated in a hospital environment and strains submitted as the Reference Center from 2000 to 2010. A total of 650 cultures were tested against first-line using the BACTEC MGIT 960 system. Resistance to first-line drugs was detected in 142 strains, (21.85%). A total of 2% were multiresistant (MDR). Of the strains resistant to first-line drugs, the greatest resistance was found to isoniazid (7.38 %) followed by rifampin and streptomycin (3.85%), pyracinamide (2%), and ethambutol 1.23%. Only one strain was resistant to four drugs. Values. In view of the resistance observed, careful surveillance of drug resistance is recommended.
尽管结核病耐药性绝不是一个新问题,但多重耐药性日益令人担忧。本研究调查了2000年至2010年在医院环境中分离出的结核分枝杆菌菌株以及作为参考中心提交的菌株中的一线耐药情况。使用BACTEC MGIT 960系统对总共650份培养物进行了一线药物检测。在142株菌株(21.85%)中检测到对一线药物的耐药性。共有2%为多重耐药(MDR)。在对一线药物耐药的菌株中,对异烟肼的耐药性最高(7.38%),其次是利福平(3.85%)和链霉素(3.85%)、吡嗪酰胺(2%)和乙胺丁醇(1.23%)。只有一株对四种药物耐药。鉴于观察到的耐药情况,建议对耐药性进行仔细监测。